Direct To Consumer Advertising: A Mixed Blessing
Direct To Consumer Advertising: A Mixed Blessing
Keywords:
Direct to consumer advertisement (DTCA), Types of DTCA, Impact of DTCAAbstract
Direct-to-consumer advertising (DTCA) is a tool used by pharmaceutical companies to market and promote medicines directly to potential consumers by means of different media but the debate for and against this is ongoing and fairly balanced. Direct to consumer promotion of pharmaceutical product is considered illegal in many parts of the world. United States and New Zealand are the only two countries which have legalized DTCA, but the advent of internet has broken all barriers. Advertisement of prescription medicines through internet and social media has made it difficult for government and regulatory authorities to effectively implement the laws which govern DTCA. In India Despite the existing legislations banning the advertisement of drugs in certain diseased conditions, lucrative advertisements of drugs and medical remedies are freely flowing in the Indian mass media nowadays. These advertisements allure the vulnerable consumers thus increasing the threat of self-medication in the society. A multi prong strategy involving government, pharmaceutical industry, doctors, medical associations and consumers is urgently required to curb the inappropriate use of DTCA. Through this article it is tried to critically appraise the advantages, disadvantages and remedies regarding direct to consumer drugs advertisement in India. [Goyal M NJIRM et al 2015; 6(3):113-117]
References
2. Boden WE, Diamond GA. DTCA for PTCA: Crossing the line in consumer health education? N Engl J Med 2008;358(21):2197–2200.
3. Kravitz RL. Direct-to-consumer advertising of prescription drugs. West J Med 2000;173:221-222.
4. Ventola CL. Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic? Pharmacy and Therapeutics 2011;36(10):669-684.5. Meshram SK, Ambade VN, Tumram NK, Borkar JL. The Critical Appraisal of Drug Advertisement Directly to Consumers: A Mockery of Drugs and Magic Remedy (Objectionable Advertisements) Act. J Indian Acad Forensic Med 2014 January-march;36(1):61-66.
6. Basics of drug ads [Internet]. U.S. Food and Drug Administration. Cited 2014 Nov 28 Available from:www.fda.gov/Drugs/ResourcesForYou/Consumers/PrescriptionDrugAdvertising/ucm 072077.htm.
7. Kusuma SK, Nunley RM, Mehta S, Genuario JW, Kennedy J, Washington Health Policy Fellows. DTCA: Improving Patient Education or Simply Increasing Pharmaceutical Profits?.December 2007 AAOS. Cited 2014 Nov 13
8. Available from:http://www.aaos.org/news/bulletin/dec07/reimbursement1.asp..
9. Bhangale V.OTC Marketing of Drugs. Proceedings of the International Conference on Marketing and Society; 2007 Apr.8-10;kerala, India:IIMK, 397-402.
10. Saha PG.Indian Otc Drug Market: Opportunities and Challenges. GJRA, October 2013;2(10):61-63.
11. Sen K. India. Advertisement Of Drugs In India: An Overview. Cited 2014 Dec 24 Available at http://www.mondaq.com/india/x/265212/food+drugs+law/ADVERTISEMENT+OF+DRUGS+IN+INDIA+AN+OVERVIEW
12. Gupta VK, Gupta CD, Patel JR. Assessment of Awareness and Attitudes towards Over-the-Counter (OTC) Drugs amongst Urban Population: A Questionnaire Based Study. RJPBCS. April – June 2012;3(2):1037-44.
13. Vats S. Impact of Direct to Consumer Advertising Through Interactive Internet Media on Working Youth. International Journal of Business and Administration Research Review. Nov-Jan2014;1(2):88-99
14. Gupta S. Emerging Indian OTC Markets.Apeejay - Journal of Management Sciences And Technology. Oct - 2013;1(1):24-29.
15. Rahman SZ, Gupta V, Anupama S, Khunte Y. Lifestyle Drugs:Concept and Impact on Society. Indian J Pharm Sci.2010;72:409-13.
16. Reddy P, Gosavi D, Reddy S. Lifestyle Drugs. Int J Pharm Pharm Sci.2012;4 suppl.5:43-45.
